Arbor
The Associate Director, Biomarker & Assay Development at Arbor Biotechnologies leads biomarker strategy, assay development, and validation for in vivo gene editing programs from discovery through IND-enabling studies. This leadership role involves overseeing bioanalytical sample analysis, managing external CROs, and mentoring a team of research associates to ensure regulatory readiness and high-quality data delivery.
Headquarters
Uniondale, New York, United States
Company Size
501-1000 employees
Founded
1993
Arbor Realty Trust is a national direct lender that provides debt capital for the multifamily and commercial real estate industries. The firm originates and acquires mortgage loans and structured financing solutions—including agency, bridge, and other capital products—to support property owners and operators. Arbor positions itself as a capital partner for real estate investors, emphasizing tailored lending, active portfolio management, and access to institutional funding sources.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Arbor.
Arbor didn’t post a salary, so this is our estimate from similar listings.
13% below the average for this role
Associate Director, Bioanalytical Sciences & Biomarkers
Arbor Biotechnologies
Manager, Clinical Biomarker Assays, Translational Science - Neuroscience
Arvinas
Scientist / Senior Scientist, Bioanalytical Sciences
Addition Therapeutics
Biomarker & Bioanalytical Development Lead
Borealisbio
Biomarker Lead
Treeline Biosciences
Senior Scientist II- Biomarker
Labcorp